SCHEMBL17153479

SCHEMBL17153479

c1cc(-c2ccc3oc4ccccc4c3c2)cc(N(c2ccc(-c3ccc4oc5ccccc5c4c3)cc2)c2ccc(-c3cccc4c3sc3ccccc34)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.44
▸ PRKDC P78527 4/20 0.39
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ PIK3CD O00329 2/20 0.33
▸ PIK3CB P42338 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ BRDT Q58F21 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ LIMK1 P53667 2/20 0.32
▸ PARP14 Q460N5 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17153482 0.99 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153431 0.99 ALOX5 (0.43) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153550 0.99 ALOX5 (0.44) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153506 0.99 ALOX5 (0.44) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153480 0.98 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153568 0.98 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153547 0.98 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153545 0.98 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153483 0.97 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL17153508 0.97 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9196842-B2 Aromatic amine derivative and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-11-24 — — US disclosed
US-9196842-B2 Aromatic amine derivative and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-11-24 — — US disclosed
US-20150287931-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 — — US disclosed
US-20150287931-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150287931-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT DDT, DDC, TYR ALOX5 3093/4885PRKDC 1914/4885PLA2G2A 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback